Literature DB >> 31633928

Conotoxins: Chemistry and Biology.

Ai-Hua Jin1, Markus Muttenthaler1,2, Sebastien Dutertre3, S W A Himaya1, Quentin Kaas1, David J Craik1, Richard J Lewis1, Paul F Alewood1.   

Abstract

The venom of the marine predatory cone snails (genus Conus) has evolved for prey capture and defense, providing the basis for survival and rapid diversification of the now estimated 750+ species. A typical Conus venom contains hundreds to thousands of bioactive peptides known as conotoxins. These mostly disulfide-rich and well-structured peptides act on a wide range of targets such as ion channels, G protein-coupled receptors, transporters, and enzymes. Conotoxins are of interest to neuroscientists as well as drug developers due to their exquisite potency and selectivity, not just against prey but also mammalian targets, thereby providing a rich source of molecular probes and therapeutic leads. The rise of integrated venomics has accelerated conotoxin discovery with now well over 10,000 conotoxin sequences published. However, their structural and pharmacological characterization lags considerably behind. In this review, we highlight the diversity of new conotoxins uncovered since 2014, their three-dimensional structures and folds, novel chemical approaches to their syntheses, and their value as pharmacological tools to unravel complex biology. Additionally, we discuss challenges and future directions for the field.

Entities:  

Year:  2019        PMID: 31633928     DOI: 10.1021/acs.chemrev.9b00207

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


  54 in total

Review 1.  Trends in peptide drug discovery.

Authors:  Markus Muttenthaler; Glenn F King; David J Adams; Paul F Alewood
Journal:  Nat Rev Drug Discov       Date:  2021-02-03       Impact factor: 84.694

Review 2.  Hormone-like conopeptides - new tools for pharmaceutical design.

Authors:  Ashlin Turner; Quentin Kaas; David J Craik
Journal:  RSC Med Chem       Date:  2020-09-24

3.  Fmoc Solid Phase Peptide Synthesis of Oxytocin and Analogues.

Authors:  Thomas Kremsmayr; Markus Muttenthaler
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Neuropeptide signalling systems - An underexplored target for venom drug discovery.

Authors:  Helen C Mendel; Quentin Kaas; Markus Muttenthaler
Journal:  Biochem Pharmacol       Date:  2020-06-30       Impact factor: 5.858

5.  Computational and Functional Mapping of Human and Rat α6β4 Nicotinic Acetylcholine Receptors Reveals Species-Specific Ligand-Binding Motifs.

Authors:  Arik J Hone; Quentin Kaas; Ireland Kearns; Fuaad Hararah; Joanna Gajewiak; Sean Christensen; David J Craik; J Michael McIntosh
Journal:  J Med Chem       Date:  2021-02-01       Impact factor: 7.446

6.  Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain.

Authors:  Nan Zheng; Sean B Christensen; Cheryl Dowell; Landa Purushottam; Jack J Skalicky; J Michael McIntosh; Danny Hung-Chieh Chou
Journal:  J Med Chem       Date:  2021-06-23       Impact factor: 7.446

Review 7.  Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors.

Authors:  Ayaulym Bekbossynova; Albina Zharylgap; Olena Filchakova
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

Review 8.  Biocatalytic synthesis of peptidic natural products and related analogues.

Authors:  Dake Liu; Garret M Rubin; Dipesh Dhakal; Manyun Chen; Yousong Ding
Journal:  iScience       Date:  2021-05-04

9.  A novel proline-rich M-superfamily conotoxin that can simultaneously affect sodium, potassium and calcium currents.

Authors:  Manyi Yang; Yubin Li; Longfei Liu; Maojun Zhou
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-06-11

10.  Venom duct origins of prey capture and defensive conotoxins in piscivorous Conus striatus.

Authors:  Ai-Hua Jin; Brett Hamilton; Subash K Rai; S W A Himaya; Paul Alewood; Richard J Lewis
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.